RF&L Wealth Management’s Boston Scientific BSX Stock Holding History

RF&L Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$215K	–	61
2025 Q2	$215K	Hold	2,000	–	–	0.14%	59
2025 Q1	$202K	Buy	+2,000	New	+$201K	0.14%	58

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RF&L Wealth Management's BSX Position: Q3 2025 in Review

RF&L Wealth Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,000 shares — an estimated $215K sold.

RF&L Wealth Management first reported a position in BSX in Q1 2025 and held it in 2 quarters. The position peaked at $215K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

RF&L Wealth Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
RF&L Wealth Management sold 2,000 Boston Scientific shares in Q3 2025, an estimated $215K.
RF&L Wealth Management first reported a position in Boston Scientific in Q1 2025 and held it in 2 quarters.
RF&L Wealth Management's Boston Scientific position peaked at $215K in Q2 2025.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on RF&L Wealth Management's 13F filing for Q3 2025, filed 8 Oct 2025.